1 | proportional | 3,382 |
2 | proportional-hazards | 115 |
3 | proportionate | 73 |
4 | subdistribution | 39 |
5 | proportional-hazard | 20 |
6 | cox-proportional | 19 |
7 | non-proportional | 19 |
8 | nonproportional | 10 |
9 | lves | 7 |
10 | mark-specific | 5 |
11 | contrived | 4 |
12 | survival-time | 4 |
13 | component-baseline | 3 |
14 | lesion-to-liver | 3 |
15 | ptx® | 3 |
16 | rved | 3 |
17 | ~bullet~home | 3 |
18 | cabg-to-pci | 2 |
19 | effect-estimate | 2 |
20 | hazards- | 2 |
21 | partial-least-squares | 2 |
22 | proximity-based | 2 |
23 | sub-distribution | 2 |
24 | 8/500-two | 1 |
25 | apixaban/warfarin | 1 |
26 | bio-ecological | 1 |
27 | cabg-pci | 1 |
28 | candesartan/placebo | 1 |
29 | corevih | 1 |
30 | coxproportional | 1 |
31 | demographic-adjusted | 1 |
32 | drowning-related | 1 |
33 | enviro006emental | 1 |
34 | euscorpiidae | 1 |
35 | exposure-mediator | 1 |
36 | extra-vasation | 1 |
37 | extreme-quartile | 1 |
38 | extreme-quintile | 1 |
39 | fī | 1 |
40 | growth-driven | 1 |
41 | hyperuricaemia-associated | 1 |
42 | ki67-associated | 1 |
43 | lesion-liver | 1 |
44 | limited-strength | 1 |
45 | log-constant | 1 |
46 | log-spline | 1 |
47 | malnutrition-inflammation-adjusted | 1 |
48 | non-rabies | 1 |
49 | p=0·97 | 1 |
50 | penfield | 1 |
51 | piecewise-constant | 1 |
52 | pois- | 1 |
53 | regression-which | 1 |
54 | regression.we | 1 |
55 | scar-to-myocardium | 1 |
56 | stereophotograph-based | 1 |
57 | vessel-tissue | 1 |
1 | 8/500-two | 1 |
2 | apixaban/warfarin | 1 |
3 | bio-ecological | 1 |
4 | cabg-pci | 1 |
5 | cabg-to-pci | 2 |
6 | candesartan/placebo | 1 |
7 | component-baseline | 3 |
8 | contrived | 4 |
9 | corevih | 1 |
10 | cox-proportional | 19 |
11 | coxproportional | 1 |
12 | demographic-adjusted | 1 |
13 | drowning-related | 1 |
14 | effect-estimate | 2 |
15 | enviro006emental | 1 |
16 | euscorpiidae | 1 |
17 | exposure-mediator | 1 |
18 | extra-vasation | 1 |
19 | extreme-quartile | 1 |
20 | extreme-quintile | 1 |
21 | fī | 1 |
22 | growth-driven | 1 |
23 | hazards- | 2 |
24 | hyperuricaemia-associated | 1 |
25 | ki67-associated | 1 |
26 | lesion-liver | 1 |
27 | lesion-to-liver | 3 |
28 | limited-strength | 1 |
29 | log-constant | 1 |
30 | log-spline | 1 |
31 | lves | 7 |
32 | malnutrition-inflammation-adjusted | 1 |
33 | mark-specific | 5 |
34 | non-proportional | 19 |
35 | non-rabies | 1 |
36 | nonproportional | 10 |
37 | p=0·97 | 1 |
38 | partial-least-squares | 2 |
39 | penfield | 1 |
40 | piecewise-constant | 1 |
41 | pois- | 1 |
42 | proportional | 3,382 |
43 | proportional-hazard | 20 |
44 | proportional-hazards | 115 |
45 | proportionate | 73 |
46 | proximity-based | 2 |
47 | ptx® | 3 |
48 | regression-which | 1 |
49 | regression.we | 1 |
50 | rved | 3 |
51 | scar-to-myocardium | 1 |
52 | stereophotograph-based | 1 |
53 | sub-distribution | 2 |
54 | subdistribution | 39 |
55 | survival-time | 4 |
56 | vessel-tissue | 1 |
57 | ~bullet~home | 3 |
1 | hazards- | 2 |
2 | pois- | 1 |
3 | p=0·97 | 1 |
4 | mark-specific | 5 |
5 | stereophotograph-based | 1 |
6 | proximity-based | 2 |
7 | ki67-associated | 1 |
8 | hyperuricaemia-associated | 1 |
9 | drowning-related | 1 |
10 | demographic-adjusted | 1 |
11 | malnutrition-inflammation-adjusted | 1 |
12 | contrived | 4 |
13 | rved | 3 |
14 | penfield | 1 |
15 | proportional-hazard | 20 |
16 | euscorpiidae | 1 |
17 | extreme-quintile | 1 |
18 | extreme-quartile | 1 |
19 | survival-time | 4 |
20 | ~bullet~home | 3 |
21 | component-baseline | 3 |
22 | log-spline | 1 |
23 | effect-estimate | 2 |
24 | proportionate | 73 |
25 | vessel-tissue | 1 |
26 | regression.we | 1 |
27 | regression-which | 1 |
28 | corevih | 1 |
29 | limited-strength | 1 |
30 | cabg-pci | 1 |
31 | cabg-to-pci | 2 |
32 | bio-ecological | 1 |
33 | proportional | 3,382 |
34 | non-proportional | 19 |
35 | cox-proportional | 19 |
36 | nonproportional | 10 |
37 | coxproportional | 1 |
38 | enviro006emental | 1 |
39 | scar-to-myocardium | 1 |
40 | growth-driven | 1 |
41 | apixaban/warfarin | 1 |
42 | extra-vasation | 1 |
43 | sub-distribution | 2 |
44 | subdistribution | 39 |
45 | candesartan/placebo | 1 |
46 | 8/500-two | 1 |
47 | lesion-liver | 1 |
48 | lesion-to-liver | 3 |
49 | exposure-mediator | 1 |
50 | proportional-hazards | 115 |
51 | non-rabies | 1 |
52 | partial-least-squares | 2 |
53 | lves | 7 |
54 | piecewise-constant | 1 |
55 | log-constant | 1 |
56 | fī | 1 |
57 | ptx® | 3 |